Cargando…

Spectral Analysis Related to Bare-Metal and Drug-Eluting Coronary Stent Implantation

BACKGROUND: The autonomic nervous system plays a central role in cardiovascular regulation; sympathetic activation occurs during myocardial ischemia. OBJECTIVE: To assess the spectral analysis of heart rate variability during stent implantation, comparing the types of stent. METHODS: This study asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Rose Mary Ferreira Lisboa, Silva, Carlos Augusto Bueno, Greco, Otaviano José, Moreira, Maria da Consolação Vieira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150665/ https://www.ncbi.nlm.nih.gov/pubmed/25029473 http://dx.doi.org/10.5935/abc.20140094

Ejemplares similares

Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Stent implantation into the tracheo-bronchial system in rabbits: histopathologic sequelae in bare metal vs. drug-eluting stents
por: Sigler, Matthias, et al.
Publicado: (2015)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Identification of functional modules induced by bare-metal stents and paclitaxel-eluting stents in coronary heart disease
por: Tang, Zhaobin, et al.
Publicado: (2018)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention(*)
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2011)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes
por: Jing, Juehua
Publicado: (2014)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
por: Si, Jiang-Hua, et al.
Publicado: (2022)

Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents
por: Mohani, Amir F., et al.
Publicado: (2018)

Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model
por: Kwon, Jin Sook, et al.
Publicado: (2011)

Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions
por: Yin, Dong, et al.
Publicado: (2017)

Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently
por: Chang, Shang-Hung, et al.
Publicado: (2013)

Vascular Responses to First-Generation Sirolimus-Eluting Stents and Bare-Metal Stents Beyond 10 Years
por: Hada, Masahiro, et al.
Publicado: (2021)

Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents
por: Murai, Kota, et al.
Publicado: (2023)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?
por: Schmidt, Wolfram, et al.
Publicado: (2018)

Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2 (nd) -Generation Drug-Eluting Stents
por: Akiyama, Yusuke, et al.
Publicado: (2022)

Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization
por: Piccolo, Raffaele, et al.
Publicado: (2021)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Coronary artery perforation treated with multiple bare metal stent implantation
por: Baskurt, Murat, et al.
Publicado: (2013)

Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
por: Chan, Pak-Hei, et al.
Publicado: (2013)

Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
por: Park, Hanbit, et al.
Publicado: (2021)

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis
por: Stettler, Christoph, et al.
Publicado: (2008)

Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents
por: Varenhorst, Christoph, et al.
Publicado: (2018)

Long term outcomes after bare metal stent implantation
por: Harikrishnan, S., et al.
Publicado: (2021)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes: a meta-analysis
por: Qiao, Yanxiang, et al.
Publicado: (2013)

Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost–benefit analysis
por: Poder, Thomas G., et al.
Publicado: (2017)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
por: Vogt, Alexander, et al.
Publicado: (2011)

Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis
por: Zhu, Zhengbin, et al.
Publicado: (2015)

Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial
por: Fahrni, Gregor, et al.
Publicado: (2020)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis
por: Meier, Pascal, et al.
Publicado: (2010)

Long-term Outcomes of Drug-eluting versus Bare-metal stent for ST-elevation Myocardial Infarction
por: Wang, Liping, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p314ma3lh5a47ap8at1m8rb06a